International Journal of Clinical Research

Objective: To observe the effect of budesonide and salbutamol on patients with acute attack of chronic bronchitis. Methods: 70 patients with acute attack of chronic bronchitis who were treated in our hospital from April 2021 to April 2022 were selected for observation. 35 patients treated with salbutamol alone were divided into the control group and 35 patients treated with budesonide and salbutamol combined were divided into the experimental group. The therapeutic effects were compared and observed. Results: the blood gas analysis indexes (PaCO2, PaO2, SpO2) of the two groups before treatment were p>0.05. Compared with the patients in the control group, the blood gas analysis indexes of the experimental group were significantly better after treatment (p<0.05); Before treatment, heart rate and respiratory rate were compared between the two groups (p>0.05); Compared with the patients in the control group, the heart rate and respiratory rate in the experimental group were significantly better after treatment (p<0.05); Compared with the patients in the control group, the disappearance time of clinical symptoms (wheezing, moist rale, asthma, cough) in the test group was significantly shorter (p<0.05). Conclusion: Budesonide and salbutamol are effective in the treatment of patients with acute attack of chronic bronchitis. They have obvious advantages in blood gas analysis indicators, heart rate, respiratory rate and the disappearance of clinical symptoms. It is recommended to promote them.

Acute Attack of Chronic Bronchitis; Budesonide; Salbutamol